Literature DB >> 25900322

Prenatal acquired cytomegalovirus infection should be considered in children with autism.

Mona-Lisa Engman1,2, Mikael Sundin1,3, Carmela Miniscalco4, Joakim Westerlund4,5, Ilona Lewensohn-Fuchs6, Christopher Gillberg4, Elisabeth Fernell4.   

Abstract

AIM: The aim of the study was to evaluate the prevalence of congenital cytomegalovirus infection (CMV) in a representative sample of children with autism spectrum disorder.
METHODS: In a representative group of 115 preschool children with autism spectrum disorder, of whom 33 also had intellectual disability, the dried blood spots from the newborn metabolic screening were analysed for CMV DNA using TaqMan polymerase chain reaction.
RESULTS: One of the 33 children with autism spectrum disorder and intellectual disability - 3% of that group - had congenital CMV infection. The corresponding prevalence in newborn infants in Sweden is 0.2%. None of the 82 children without intellectual disability had congenital CMV.
CONCLUSION: The finding lends some further support for congenital CMV being one of the many aetiologies underlying autism spectrum disorder with intellectual disability. The rate of 3% of congenital CMV in children with autism spectrum disorder with intellectual disability has implications for the medical work-up. The finding of congenital CMV also indicates the need for repeated hearing assessments in the child. There is a need for similar studies with much larger samples. ©2015 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Autism; Congenital cytomegalovirus infection; Dried blood spots; Intellectual disability

Mesh:

Year:  2015        PMID: 25900322     DOI: 10.1111/apa.13032

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  7 in total

1.  Congenital Cytomegalovirus Infection in Children with Autism Spectrum Disorder: Systematic Review and Meta-Analysis.

Authors:  Kaori Maeyama; Kazumi Tomioka; Hiroaki Nagase; Mieko Yoshioka; Yasuko Takagi; Takeshi Kato; Masami Mizobuchi; Shinji Kitayama; Satoshi Takada; Masashi Nagai; Nana Sakakibara; Masahiro Nishiyama; Mariko Taniguchi-Ikeda; Ichiro Morioka; Kazumoto Iijima; Noriyuki Nishimura
Journal:  J Autism Dev Disord       Date:  2018-05

2.  Hsa-miR-27b is up-regulated in cytomegalovirus-infected human glioma cells, targets engrailed-2 and inhibits its expression.

Authors:  Linqian Wang; Ming Yang; Shijing Liao; Wei Liu; Gan Dai; Guojun Wu; Liyu Chen
Journal:  Exp Biol Med (Maywood)       Date:  2017-03-26

3.  An Italian Prospective Experience on the Association Between Congenital Cytomegalovirus Infection and Autistic Spectrum Disorder.

Authors:  Francesca Garofoli; Giuseppina Lombardi; Simona Orcesi; Camilla Pisoni; Iolanda Mazzucchelli; Micol Angelini; Umberto Balottin; Mauro Stronati
Journal:  J Autism Dev Disord       Date:  2017-05

4.  Prevalence of Congenital Cytomegalovirus Infection Assessed Through Viral Genome Detection in Dried Blood Spots in Children with Autism Spectrum Disorders.

Authors:  Ivan Gentile; Emanuela Zappulo; Maria Pia Riccio; Sandro Binda; Laura Bubba; Laura Pellegrinelli; Domenico Scognamiglio; Francesca Operto; Lucia Margari; Guglielmo Borgia; Carmela Bravaccio
Journal:  In Vivo       Date:  2017 May-Jun       Impact factor: 2.155

5.  Congenital human cytomegalovirus infection and neurologic diseases in newborns.

Authors:  Xin-Yan Zhang; Feng Fang
Journal:  Chin Med J (Engl)       Date:  2019-09-05       Impact factor: 2.628

6.  Transcriptomic Analysis Reveals Abnormal Expression of Prion Disease Gene Pathway in Brains from Patients with Autism Spectrum Disorders.

Authors:  Salvo Danilo Lombardo; Giuseppe Battaglia; Maria Cristina Petralia; Katia Mangano; Maria Sofia Basile; Valeria Bruno; Paolo Fagone; Rita Bella; Ferdinando Nicoletti; Eugenio Cavalli
Journal:  Brain Sci       Date:  2020-03-29

Review 7.  Association between Viral Infections and Risk of Autistic Disorder: An Overview.

Authors:  Ahmad Naqib Shuid; Putri Ayu Jayusman; Nazrun Shuid; Juriza Ismail; Norazlin Kamal Nor; Isa Naina Mohamed
Journal:  Int J Environ Res Public Health       Date:  2021-03-10       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.